David S. Kinard - 19 Feb 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President, Human Resources, Corporate Affairs and Administration
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for David S. Kinard
Issuer symbol
ELAN
Transactions as of
19 Feb 2025
Net transactions value
-$201,960
Form type
4
Filing time
21 Feb 2025, 18:17:07 UTC
Previous filing
05 Mar 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +40,247 +27% $0.000000 191,903 19 Feb 2025 Direct F1
transaction ELAN Common Stock Tax liability $201,960 -17,968 -9.4% $11.24 173,935 19 Feb 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 454 shares acquired on April 30, 2024, 524 shares acquired on July 31, 2024, 464 shares acquired on October 31, 2024, and 568 shares acquired on January 31, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.

Remarks:

Executive Vice President, Human Resources, Corporate Affairs and Administration